Our observation of enhanced expression of CD11b in OG-86-cultured KD cells raised a question as to whether concomitant pharmacologic targeting of mTORC1 and LSD1 might collaborate to further induce a molecular differentiation programme in AML cells. The gene discussed is ITGAM; the disease is acute myeloid leukemia.